Results 171 to 180 of about 86,566 (299)

No association between use of tenofovir disoproxil fumarate, etravirine, or integrase-strand transfer inhibitors and acquisition or severe outcomes of SARS-CoV-2 infection in people with HIV in the Netherlands

, 2023
Myrthe L. Verburgh, Marc van der Valk, Bart Rijnders, Peter Reiss, Ferdinand W.N.M. Wit   +4 more
openalex   +1 more source

Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium.

The Lancet HIV, 2022
B. Neesgaard, L. Greenberg, J. Miró, K. Grabmeier-Pfistershammer, G. Wandeler, Colette Smith, S. De Wit, F. Wit, A. Pelchen-Matthews, C. Mussini, A. Castagna, C. Pradier, A. d’Arminio Monforte, J. Vehreschild, A. Sönnerborg, A. V. Anne, A. Carr, L. Bansi-Matharu, J. Lundgren, H. Garges, F. Rogatto, R. Zangerle, H. Günthard, L. D. Rasmussen, C. Necsoi, M. van der Valk, M. Menozzi, C. Muccini, L. Peters, A. Mocroft, L. Ryom   +30 more
semanticscholar   +1 more source

Therapeutic Opportunities in Infectious Diseases: Highlights from the Society of Medicines Research Symposium, held on March 14th 2013 at the National Heart & Lung Institute, London, UK [PDF]

, 2013
Alderton, W K, Anderson, Rosaleen, Collingwood, S P, Pryde, D C   +3 more
core   +1 more source

From protease inhibitors to integrase strand transfer inhibitors: the evolution of HIV drug resistance management

Zhongguo linchuang yanjiu
Antiretroviral therapy (ART) has significantly improved the prognosis of HIV/AIDS patients and has become an important global strategy for the prevention and control of AIDS.
HU Zhiliang, YANG Yongfeng
doaj   +1 more source

HIV-1 Integrase Inhibitors: A Comparative Review of Efficacy and Safety

Drugs, 2020
K. Scarsi, J. Havens, A. Podany, Sean N. Avedissian, C. Fletcher   +4 more
semanticscholar   +1 more source

Development of a G118R mutation in HIV-1 integrase following a switch to dolutegravir monotherapy leading to cross-resistance to integrase inhibitors [PDF]

, 2016
Bluma Brenner, Réjean Thomas, José Luís Blanco, Ruxandra-Ilinca Ibanescu, Maureen Oliveira, Thibault Mésplède, Olga Golubkov, Michel Roger, Féderico García, Estebán Martínez, Mark A. Wainberg   +10 more
openalex   +1 more source

Single‐dose pharmacokinetics and safety of ACC017, a novel HIV integrase inhibitor, in healthy adult participants: A first‐in‐human study [PDF]

Chaoying Hu, Y. Li, Yijun Zhou, Dong Zhao, Hui‐Yu Sun, Bin Li, Jing Ji, F. Zhang, Hong Qin, Yun Xing   +9 more
openalex   +1 more source

Effectiveness of integrase strand transfer inhibitors in HIV‐infected treatment‐experienced individuals across Europe [PDF]

, 2022
Barbara Rossetti, Massimiliano Fabbiani, Domenico Di Carlo, Francesca Incardona, Ana Abecasis, Perpétua Gómes, Anna María Geretti, Carole Seguin‐Devaux, Féderico García, Rolf Kaiser, Sara Modica, Adrian Shallvari, Anders Sönnerborg, Maurizio Zazzi, EuResist Network, INTEGRATE study group   +14 more
openalex   +1 more source

HIV Integrase Inhibitor [PDF]

, 2020
openaire   +1 more source

CCR5 antagonists used as topical microbicides modulate CCR5 expression and may potentially compound HIV infection [PDF]

, 2017
CCR5 antagonists, such as Maraviroc (MVC) and 5P12-RANTES, are being evaluated as HIV preventatives. The advantage of these drugs is that they restrict HIV entry via CCR5 receptor.
Laux, Julie
core